# Immunoassay, Anti-Seizure Drug
> **Product code: NWM** · Class II — Moderate Risk (510(k) clearance required) · Clinical Toxicology · 21 CFR 862.3350
## Classification
- **FDA Product Code:** NWM
- **Device class:** Class II — Moderate Risk (510(k) clearance required)
- **Regulation:** 21 CFR 862.3350
- **Review panel:** TX
- **Medical specialty:** Clinical Toxicology
- **Submission type:** 1
- **GMP exempt:** N
- **Life sustaining:** N
- **Implant:** N
- **Third-party review:** Y
## Definition

To aid in management of patients treated with anti-seizure drug.

## Market data
- **Cleared 510(k) submissions:** 5
- **Registered establishments:** 2
## Source
- [FDA Device Classification](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?ID=NWM)
---
*AI Analytics · CC0 1.0*